SCHEMBL13488100

SCHEMBL13488100

CC1(C)c2ccccc2-c2ccc(-c3c4ccccc4c(-c4nc5ccccc5n4-c4ccccc4)c4ccc(-c5ccc6ccccc6c5)cc34)cc21

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK10 P53779 3/20 0.37
PTGER4 P35408 1/20 0.36
RECQL P46063 1/20 0.36
MAPK1 P28482 1/20 0.35
HTT P42858 1/20 0.35
ESR1 P03372 2/20 0.34
ESR2 Q92731 2/20 0.34
ATR Q13535 1/20 0.33
PIK3CD O00329 1/20 0.33
PIK3CA P42336 1/20 0.33
MTOR P42345 1/20 0.33
FLT3 P36888 1/20 0.32
PRKACA P17612 1/20 0.32
RPS6KB1 P23443 1/20 0.32
GSK3B P49841 1/20 0.32
ROCK1 Q13464 1/20 0.32
GRIA1 P42261 1/20 0.32
CACNG8 Q8WXS5 1/20 0.32
CACNG2 Q9Y698 1/20 0.32
GSR P00390 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13488042 0.96 MAPK10 (0.39) MAPK10PTGER4RECQLMAPK1HTT
SCHEMBL13488182 0.95 RECQL (0.39) PTGER4RECQLMAPK1HTTESR1
SCHEMBL13487788 0.95 PTGER4 (0.36) MAPK10PTGER4RECQLMAPK1HTT
SCHEMBL13487936 0.94 RECQL (0.38) PTGER4RECQLMAPK1HTTESR1
SCHEMBL12247131 0.93 RECQL (0.38) MAPK10PTGER4RECQLMAPK1HTT
SCHEMBL13487787 0.93 RECQL (0.38) PTGER4RECQLMAPK1HTTESR1
SCHEMBL26344965 0.92 RECQL (0.42) PTGER4RECQLMAPK1HTTESR1
SCHEMBL13651081 0.91 FLT3 (0.38) PTGER4RECQLMAPK1HTTESR1
SCHEMBL13488112 0.91 ESR1 (0.41) PTGER4RECQLMAPK1HTTESR1
SCHEMBL18925699 0.91 ESR1 (0.41) PTGER4RECQLMAPK1HTTESR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100045170-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2010-02-25 US disclosed
US-20100045170-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2010-02-25 US disclosed
EP-2108689-A2 Novel organic electroluminescent compounds and organic electroluminescent device using the same Gracel Display Inc. (KR) 2009-10-14 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100045170-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same OCIAD1, OCIAD2, ORMDL3 MAPK10 1970/4885PTGER4 2083/4885RECQL 3661/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.